Upperton Pharma Solutions is an independent CDMO providing specialist Spray Drying and formulation services to the Pharmaceutical and Biotechnology industries. The company is a world-leader in Spray Drying technology, and offers a complete development package, from early stage feasibility studies and formulation development, to process optimisation, scale up and clinical trial (IMP) manufacturing, supporting a range of dosage forms. Comprehensive product testing and ICH stability studies are available through an extensive range of analytical capabilities.
Based in Nottingham, UK, and founded in 1999, our primary focus has always been on the versatile technology of Spray Drying and we have built up the expertise to support even the most challenging of molecules. The company has an extensive, multinational client-base, ranging from small start-ups to top pharma companies and we pride ourselves on our client-focused, flexible approach and scientific excellence.
Upperton Pharma Solutions
Albert Einstein Centre
Nottingham Science Park
Nottingham NG7 2TN
United Kingdom
+44 (0) 115 855 7050
www.upperton.com
contact@upperton.com
Why Choose Upperton Pharma Solutions?
Upperton is a specialist pharmaceutical CDMO that can, within days of initial contact, start feasibility studies with only a few milligrams of a client’s drug candidate. We offer our clients a complete development package, across all dry powder dosage forms: powders, capsules, tablets, devices for nasal and pulmonary delivery. With experience of working on a range of dosage forms and the expertise to develop the most challenging molecules. From the beginning, our clients will talk to an expert scientific team, who will manage projects with a science-led approach. More Info
UpperNoseTM
The ability to self-administer small molecules, biologics and vaccines is highly attractive yet the knowledge and expertise necessary to rapidly develop products for this delivery route remains limited in the CDMO space. To address this growing demand, Upperton has developed UpperNoseTM, a unique nasal product development platform.
The UpperNoseTM platform can be applied to liquid and dry powder formulations and utilises the knowledge and expertise of the highly experienced Upperton scientific team to develop your molecule in an efficient and timely manner.
More Info
Pulmonary Delivery
Delivery of treatments by inhalation, directly into the lungs (pulmonary) remains a popular approach to evoke a local or even a systemic response. The Upperton scientific team is highly experienced in the development of pulmonary products and has the expertise to support the delivery of therapeutics as a dry powder or liquid. More Info
